Chiesi Farmaceutici SpA

Poland

All drugs from this manufacturer

  • CUROSURF

    The medicine is used to treat and prevent respiratory distress syndrome (RDS) in newborns, especially premature infants, who are born with a deficiency of natural surfactant.

    Dosage form: suspension for inhalation and bronchial use

    Active substance Dosage
    poractant alfa 80 mg/ml

    ATC: R07AA02